Key Insights

Highlights

Treatment Research

2 treatments under study, led by Non Invasive Prenatal Test

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2

Clinical Trials (2)

Research Network

Common Treatments

  • Non Invasive Prenatal Test1
  • Genome Sequencing Gs1

Active Sponsors

  • Rennes University Hospital1
  • Columbia University1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Related Conditions

  • Miscarriage In First Trimester1

Activity Timeline